Search results
Metastatic gastric adenocarcinoma discovered in the bone marrow. Ekaterina Proskuriakova, Vaisny Balamurali, Anuradha Hooda, Paramjeet Khosla. 20 September 2024. Case of B-acute lymphoblastic leukaemia with t (1;19) (q23;p13.3) TCF3::PBX1 and co-occurring CBL mutation in an elderly patient.
Tracheal airway obstruction induced by a large glomangioma: discussion of management and literature review. Bassel Hallak, Stephane Yerly, Salim Bouayed, Lynda Zidi. BMJ Case Reports CP Sep 2024, 17 (9) e261481; DOI: 10.1136/bcr-2024-261481. Unresectable squamous cell carcinoma in a patient with spina bifida.
In this review, we outline 10 critical challenges and opportunities in computational immuno-oncology, emphasizing the importance of robust computational strategies and interdisciplinary collaborations amid the constantly evolving interplay between clinical needs and technological innovation.
22 sie 2024 · Enhanced immune activation from ICI can theoretically result in osteoclast activation, bone loss and fracture. The objective of this study was to evaluate the incidence rates of major osteoporotic fractures (MOFs) in patients with melanoma treated with ICI.
Abstract. Immune checkpoint inhibitors (ICIs) have revolutionized oncology treatment. However, their success is mitigated by the recognition that ICI-induced immune-related adverse events (irAEs) pose considerable challenges to patients and clinicians.
5 wrz 2023 · ASIR, ASDR and age-standardised DALYs in 2019, and relative change in incident, death and DALYs cases of early-onset cancers from 1990 to 2019. Globally, the incident and death cases of early-onset cancers increased by 79.0% and 28.5% in 2019, respectively .
31 paź 2017 · Specifically, the odds ratios per 25 nmol/L increase in genetically determined 25 (OH)D concentrations were 0.92 (95% confidence interval 0.76 to 1.10) for colorectal cancer, 1.05 (0.89 to 1.24) for breast cancer, 0.89 (0.77 to 1.02) for prostate cancer, and 1.03 (0.87 to 1.23) for lung cancer.
